The Human Monoacylglycerol Acyltransferase 2 Inhibitor VB‐85387 Is Associated With Weight Loss in Mice With Obesity
ABSTRACT Background GLP‐1 therapies for obesity are limited by side effects and weight regain is common after treatment ends. Therefore, alternative treatments with new mechanisms are needed for sustained weight loss. Human MOGAT2 regulates triglyceride metabolism and its inhibition reduces weight i...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wiley
2026-04-01
|
| Col·lecció: | Obesity Science & Practice |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1002/osp4.70131 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|